Literature DB >> 23480673

An assessment of the impact of behavioural cognitions on function in patients partaking in a trial of early home-based progressive resistance training after total hip replacement surgery.

T Okoro1, V Morrison, P Maddison, A B Lemmey, J G Andrew.   

Abstract

BACKGROUND: Control cognitions have been directly related to positive engagement with rehabilitation regimes. The impact of such cognitions on recovery following surgery is not well understood.
PURPOSE: To assess whether perceived control cognitions predict function 9-12 months following total hip replacement (THR).
METHODS: Prospective cohort study performed as part of a randomised controlled trial. Behavioural cognitions (BC) (recovery locus of control (RLOC); perceived external behavioural control (PEBC))) and subjective functional outcome measures (Oxford hip score (OHS) and a reduced version of the Western Ontario and McMasters University Osteoarthritis Function scale (rWOMAC PF)) were administered pre-operatively and up to 12 months post-operatively to 50 patients randomised to home-based progressive resistance training (N = 26) or standard rehabilitation (N = 24), post-THR. Regression analysis investigated variance in functional scores.
RESULTS: Group randomisation had no effect on BC. RLOC and OHS (6 months) correlated significantly with 12-month OHS, with 6-month OHS predicting 62.3% of the variance in 12-month OHS. 12-month rWOMAC PF was determined by each of its three previous assessments (pre-operative 8.8%, 6 weeks 17.8% and 6 months 67.3%). Variance in functional gain at 12 months (OHS and rWOMAC PF) was explained by pre-operative OHS and rWOMAC PF (63.7% and 63.8%, respectively).
CONCLUSIONS: BC had no impact on functional outcome in this population. Subjectively assessed function at 12 months, as well as the levels of functional gain over time, was best explained by the patients' earlier functional status. Implications for Rehabilitation It is important to assess psychological factors such as poor pre-operative mental health and pain catastrophising in patients undergoing joint replacement surgery as these factors have an adverse effect on subjective patient outcomes. Pre-operative behavioural cognitions appear to have no impact on subjective functional outcome at 12 months post-THR. The pre-existing functional status of the patient appears to be most predictive of subjective function at 12 months post-THR, implying that perhaps earlier surgery may be optimal before the onset of a decline in function.

Entities:  

Mesh:

Year:  2013        PMID: 23480673     DOI: 10.3109/09638288.2013.770082

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  4 in total

1.  Is social support associated with patient-reported outcomes after joint replacement? A systematic review and meta-analysis.

Authors:  V Wylde; S K Kunutsor; E Lenguerrand; J Jackson; A W Blom; A D Beswick
Journal:  Lancet Rheumatol       Date:  2019-10-02

Review 2.  Extracellular Vesicles from Mesenchymal Stem Cells as Potential Treatments for Osteoarthritis.

Authors:  Nur Azira Mohd Noor; Asma Abdullah Nurul; Muhammad Rajaei Ahmad Mohd Zain; Wan Khairunnisaa Wan Nor Aduni; Maryam Azlan
Journal:  Cells       Date:  2021-05-22       Impact factor: 6.600

3.  Fracture in the Elderly Multidisciplinary Rehabilitation (FEMuR): study protocol for a phase II randomised feasibility study of a multidisciplinary rehabilitation package following hip fracture [ISRCTN22464643].

Authors:  Nefyn H Williams; Claire Hawkes; Nafees Ud Din; Jessica L Roberts; Joanna M Charles; Val L Morrison; Zoe Hoare; Rhiannon T Edwards; Glynne Andrew; Swapna Alexander; Andrew B Lemmey; Bob Woods; Catherine Sackley; Pip Logan; David Hunnisett; Kevin Mawdesley; Clare Wilkinson
Journal:  Pilot Feasibility Stud       Date:  2015-04-07

Review 4.  Extracellular vesicles: Potential role in osteoarthritis regenerative medicine.

Authors:  Xiaoxin Wu; Yuewen Wang; Yin Xiao; Ross Crawford; Xinzhan Mao; Indira Prasadam
Journal:  J Orthop Translat       Date:  2019-12-06       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.